Manish K Thakur
Clinical Assistant Professor, Department of Medicine
1000 Oakland Drive
Kalamazoo, MI 49008
Dr. Manish Thakur is a Clinical Assistant Professor in the Department of Medicine. He is Board Certified in Internal Medicine, Hematology and Medical Oncology. He is employed with the West Michigan Cancer Center. He completed his Residency in Internal Medicine at Wayne State University - Detroit Medical Center in June 2013. He then completed a Fellowship in Hematology and Oncology also at Wayne State University - Karmanos Cancer Center in June 2016. He specializes in the field of Lung Cancer with strong interest in the area of Molecular Therapeutics. His research area has been Population Epidemiology in Lung Cancer. He also has special interest in Prostate Cancer research and has authored peer reviewed papers and review articles in this field.
- American Board of Internal Medicine (Internal Medicine)
- American Board of Internal Medicine (Hematology)
- American Board of Internal Medicine (Medical Oncology)
Education and Training
- Fellowship 2016, Hematology/ Oncology, Wayne State University
- Residency 2013, Internal Medicine, Wayne State University
- Prostate Cancer
- Lung Cancer
Thakur M., Ruterbusch J., Schwartz A., Gadgeel S., Beebe-Dimmer J., Wozniak A. Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data Journal of Thoracic Oncology. 2018;13:46-53. doi: 10.1016/j.jtho.2017.09.1964.
Thakur M.K., Heilbrun L., Dobson K., Boerner J., Stark K., Li J., Smith D., Heath E., Fontana J., Vaishampayan U. Phase I Trial of the Combination of Docetaxel, Prednisone, and Pasireotide in Metastatic Castrate-Resistant Prostate Cancer Clinical Genitourinary Cancer. 2018;16:e695-e703. doi: 10.1016/j.clgc.2018.01.019.
Thakur M., Wozniak A. Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma Lung Cancer: Targets and Therapy. 2017;8:13-19. doi: 10.2147/LCTT.S104207.
Piotrowska Z., Liu E., Varga A., Thakur M., Narayanan V., Liu S.V., Neal J., Spiegel M., Solomon B., Yu H., Ou S.H.I., Papadimitrakopoulou V.A., Gadgeel S., Camidge D.R., Soria J.C., Wakelee H., Goldman J., Kopani K., Rolfe L., Sequist L.V. Rociletinib-associated cataracts in EGFR-mutant NSCLC Annals of Oncology. 2016;27:vi428. doi: 10.1093/annonc/mdw383.39.
Thakur M., Gadgeel S. Predictive and Prognostic Biomarkers in Non-Small Cell Lung Cancer Seminars in Respiratory and Critical Care Medicine. 2016;37:760-770. doi: 10.1055/s-0036-1592337.
Thakur M., Vaishampayan U. Multifaceted and personalized therapy of advanced prostate cancer Current Opinion in Oncology. 2016;28:222-231. doi: 10.1097/CCO.0000000000000284.
Thakur M.K., Heilbrun L.K., Sheng S., Stein M., Liu G., Antonarakis E.S., Vaishampayan U., Dzinic S.H., Li X., Freeman S., Smith D., Heath E.I. A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study Investigational New Drugs. 2016;34:112-118. doi: 10.1007/s10637-015-0307-6.
Thakur M., Revankar S. In vitro interaction of caspofungin and immunosuppressives against agents of mucormycosis Journal of Antimicrobial Chemotherapy. 2011;66:2312-2314. doi: 10.1093/jac/dkr297.